Sign in or create an account to add this stock to your watchlist.
About Avinger (NASDAQ:AVGR)
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900
Debt
Debt-to-Equity RatioN/A
Current Ratio1.75
Quick Ratio1.42
Price-To-Earnings
Trailing P/E Ratio-0.03
Forward P/E Ratio-1.04
P/E GrowthN/A
Sales & Book Value
Annual Sales$9.93 million
Price / Sales1.13
Cash FlowN/A
Price / CashN/A
Book Value$2.14 per share
Price / Book0.94
Profitability
EPS (Most Recent Fiscal Year)($70.07)
Net Income$-48,730,000.00
Net Margins-529.24%
Return on EquityN/A
Return on Assets-187.84%
Miscellaneous
Employees65
Outstanding Shares5,560,000
Avinger (NASDAQ:AVGR) Frequently Asked Questions
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
When did Avinger's stock split? How did Avinger's stock split work?
Avinger's stock reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.
How were Avinger's earnings last quarter?
Avinger (NASDAQ:AVGR) released its quarterly earnings data on Monday, May, 14th. The medical device company reported ($5.37) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.84) by $4.53. The medical device company earned $1.81 million during the quarter. View Avinger's Earnings History.
Who are some of Avinger's key competitors?
Some companies that are related to Avinger include Obalon Therapeutics (OBLN), Nephros (NEPH), Presbia (LENS), CELLECT BIOTECH/S (APOP), Valeritas (VLRX), Lianluo Smart (LLIT), Pro-Dex (PDEX), DarioHealth (DRIO), AIT Therapeutics (AITB), Interpace Diagnostics Gr (IDXG), PAVmed (PAVM), Cytori Therapeutics (CYTX), STRATA Skin Sciences (SSKN), Cytocore common stock (MDIT) and InVivo Therapeutics (NVIV).
Who are Avinger's key executives?
Avinger's management team includes the folowing people:
- Dr. John Bush Simpson, Founder (Age 74)
- Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 56)
- Mr. Matthew B. Ferguson, Chief Bus. Officer & CFO (Age 50)
- Mr. Keith Schaefer, Chief Operating Officer
- Mr. Himanshu N. Patel, Chief Technology Officer (Age 58)
When did Avinger IPO?
(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.
Has Avinger been receiving favorable news coverage?
Press coverage about AVGR stock has trended somewhat positive on Monday, Accern reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Avinger earned a media sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 45.33 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Avinger?
Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avinger's stock price today?
One share of AVGR stock can currently be purchased for approximately $2.01.
How big of a company is Avinger?
Avinger has a market capitalization of $11.18 million and generates $9.93 million in revenue each year. The medical device company earns $-48,730,000.00 in net income (profit) each year or ($70.07) on an earnings per share basis. Avinger employs 65 workers across the globe.
How can I contact Avinger?
Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]
MarketBeat Community Rating for Avinger (AVGR)
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Avinger (NASDAQ:AVGR) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Avinger in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Hold | Hold |
| Consensus Rating Score: | 3.00 | 3.00 | 2.25 | 2.25 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | $200.00 |
| Price Target Upside: | N/A | N/A | N/A | 32,478.60% upside |
Avinger (NASDAQ:AVGR) Consensus Price Target History
Avinger (NASDAQ:AVGR) Analyst Ratings History
Show:
(Data available from 5/28/2016 forward)
Avinger (NASDAQ:AVGR) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Avinger (NASDAQ AVGR) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.50%
Institutional Ownership Percentage: 2.79%
Avinger (NASDAQ AVGR) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/16/2018 | Himanshu Patel | Insider | Buy | 50 | $1,000.00 | $50,000.00 | 2,484 |  |
| 11/15/2017 | John B Ph D Md Simpson | Insider | Sell | 1,074,130 | $0.25 | $268,532.50 | | |
| 11/13/2017 | John B Ph D Md Simpson | Chairman | Sell | 454,584 | $0.27 | $122,737.68 | | |
| 8/16/2016 | Jeffrey M Soinski | CEO | Buy | 57,100 | $3.50 | $199,850.00 | 59,345 | |
| 8/16/2016 | Matthew Ferguson | CFO | Buy | 7,000 | $3.50 | $24,500.00 | 25,754 | |
| 5/6/2016 | Donald A Lucas | Director | Sell | 9,309 | $12.58 | $117,107.22 | | |
| 5/6/2016 | Himanshu Patel | Insider | Sell | 10,000 | $13.40 | $134,000.00 | 87,220 | |
| 4/15/2016 | John B Ph D Md Simpson | Major Shareholder | Sell | 75,111 | $13.11 | $984,705.21 | | |
| 3/11/2016 | John B Ph D Md Simpson | Major Shareholder | Sell | 40,000 | $11.44 | $457,600.00 | | |
| 3/11/2016 | Matthew Ferguson | CFO | Buy | 1,500 | $11.37 | $17,055.00 | 17,754 | |
| 12/14/2015 | Donald A Lucas | Director | Sell | 2,500 | $16.22 | $40,550.00 | | |
| 12/11/2015 | Donald A Lucas | Director | Sell | 4,000 | $15.92 | $63,680.00 | | |
| 11/25/2015 | John B Ph D Md Simpson | Major Shareholder | Sell | 100,000 | $17.26 | $1,726,000.00 | | |
| 11/24/2015 | John B Ph D Md Simpson | Chairman | Sell | 42,445 | $17.20 | $730,054.00 | | |
| 2/4/2015 | Himanshu Patel | CTO | Sell | 1,731 | $13.00 | $22,503.00 | | |
| 2/4/2015 | James Cullen | Director | Sell | 2,307 | $13.00 | $29,991.00 | | |
| 2/4/2015 | Matthew Ferguson | CFO | Sell | 1,154 | $13.00 | $15,002.00 | | |
(Data available from 1/1/2013 forward)
Avinger (NASDAQ AVGR) News Headlines
| Source: |
|
Avinger (NASDAQ:AVGR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Avinger (NASDAQ:AVGR) Income Statement, Balance Sheet and Cash Flow Statement
Avinger (NASDAQ AVGR) Stock Chart for Monday, May, 28, 2018
Loading chart…
